NCT03361657 (PaCO2-EtCO2) is a clinical trial in Intraoperative Ventilation, sponsored by Assiut University.

Who is sponsoring NCT03361657?

NCT03361657 is sponsored by Assiut University.

What condition does NCT03361657 study?

NCT03361657 studies Intraoperative Ventilation.

Is NCT03361657 still recruiting?

NCT03361657 is currently completed. Last updated 8 April 2020.

Last reviewed 2020-04-08 · How we verify

NCT03361657: PaCO2-EtCO2

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Arterial to End-Tidal Carbon Dioxide Difference During Pediatric Laparoscopic Surgeries

Completed Last updated 8 April 2020

What this trial tests

trial in Intraoperative Ventilation in 29 participants. Completed in 1 December 2018.

Timeline

20 December 2017

Primary endpoint
1 December 2018

1 December 2018

Quick facts

Lead sponsor	Assiut University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	29
Start date	20 December 2017
Primary completion	1 December 2018
Estimated completion	1 December 2018
Sites	1 location across Egypt

Conditions studied

Intraoperative Ventilation — all drugs for Intraoperative Ventilation →

Sponsor

Assiut University

Who can join

Adults 1 to 6, any sex, with Intraoperative Ventilation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Studying the arterial to end-tidal carbon dioxide difference in children undergoing laparoscopic surgeries under different intra-abdominal pressures is of extreme importance. This is because both hyper and hypocarbia are detrimental in this vulnerable age group.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

End-tidal carbon dioxide measurements as a surrogate to arterial carbon dioxide during pediatric laparoscopic surgeries: a prospective observational cohort study.
Abdel-Ghaffar HS, Bakr MA, Osman MA, Hanna SGL, et al · · 2024 · cited 1× · PMID 34411630 · DOI 10.1016/j.bjane.2021.07.036

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03361657 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 8 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03361657.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing